Exchange Traded Concepts, LLC Axogen, Inc. Transaction History

Exchange Traded Concepts, LLC

  • $4.74 Billion
  • Q4 2024

A detailed history of Exchange Traded Concepts, LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 64,318 shares of AXGN stock, worth $1.17 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
64,318
Previous 74,742 13.95%
Holding current value
$1.17 Million
Previous $1.05 Million 1.15%
% of portfolio
0.02%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025
SELL
$12.47 - $17.19 $129,987 - $179,188
-10,424 Reduced 13.95%
64,318 $1.06 Million
Q3 2024

Oct 10, 2024
SELL
$7.52 - $14.69 $546,824 - $1.07 Million
-72,716 Reduced 49.31%
74,742 $1.05 Million
Q2 2024

Aug 13, 2024
BUY
$5.67 - $8.06 $231,415 - $328,960
40,814 Added 38.27%
147,458 $1.07 Million
Q1 2024

Apr 15, 2024
BUY
$6.63 - $10.69 $177,558 - $286,288
26,781 Added 33.53%
106,644 $860,000
Q4 2023

Jan 05, 2024
SELL
$3.61 - $7.76 $100,368 - $215,751
-27,803 Reduced 25.82%
79,863 $545,000
Q3 2023

Oct 18, 2023
BUY
$4.68 - $9.26 $81,815 - $161,883
17,482 Added 19.38%
107,666 $538,000
Q2 2023

Jul 20, 2023
SELL
$8.5 - $10.38 $66,682 - $81,431
-7,845 Reduced 8.0%
90,184 $823,000
Q1 2023

Apr 12, 2023
BUY
$7.53 - $10.95 $151,834 - $220,795
20,164 Added 25.9%
98,029 $926,000
Q4 2022

Jan 17, 2023
SELL
$9.44 - $13.09 $120,718 - $167,394
-12,788 Reduced 14.11%
77,865 $777,000
Q3 2022

Oct 07, 2022
SELL
$8.14 - $12.25 $28,970 - $43,597
-3,559 Reduced 3.78%
90,653 $1.08 Million
Q2 2022

Jul 20, 2022
SELL
$6.99 - $10.0 $1.06 Million - $1.51 Million
-151,117 Reduced 61.6%
94,212 $772,000
Q1 2022

Apr 26, 2022
SELL
$7.26 - $10.7 $391,379 - $576,826
-53,909 Reduced 18.02%
245,329 $1.95 Million
Q4 2021

Jan 13, 2022
BUY
$8.8 - $16.0 $814,378 - $1.48 Million
92,543 Added 44.77%
299,238 $2.8 Million
Q3 2021

Oct 18, 2021
BUY
$15.23 - $21.72 $556,900 - $794,213
36,566 Added 21.49%
206,695 $3.27 Million
Q2 2021

Jul 30, 2021
BUY
$17.8 - $23.5 $438,948 - $579,510
24,660 Added 16.95%
170,129 $3.68 Million
Q1 2021

Apr 20, 2021
BUY
$17.18 - $22.6 $697,508 - $917,560
40,600 Added 38.71%
145,469 $2.95 Million
Q4 2020

Jan 19, 2021
BUY
$11.5 - $17.96 $548,354 - $856,386
47,683 Added 83.38%
104,869 $1.88 Million
Q3 2020

Oct 30, 2020
BUY
$10.62 - $13.12 $238,195 - $294,268
22,429 Added 64.53%
57,186 $665,000
Q2 2020

Jul 15, 2020
BUY
$7.35 - $10.81 $156,606 - $230,328
21,307 Added 158.42%
34,757 $321,000
Q1 2020

Apr 14, 2020
BUY
$8.38 - $17.34 $64,844 - $134,176
7,738 Added 135.47%
13,450 $140,000
Q4 2019

Jan 22, 2020
BUY
$11.18 - $18.6 $63,860 - $106,243
5,712 New
5,712 $102,000

Others Institutions Holding AXGN

# of Institutions
165
Shares Held
36.2M
Call Options Held
230K
Put Options Held
400
View Full List

About Axogen, Inc.

AXGN Quotes by TradingView
  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $770M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email